Go Pro

Andrew Fein Analyst Performance

MD/Senior Analyst at HC Wainwright

Andrew Fein is a stock analyst at HC Wainwright focused in the healthcare sector, covering 74 publicly traded companies. Over the past year, Andrew Fein has issued 81 stock ratings, including buy and hold recommendations. While full access to Andrew Fein's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Andrew Fein's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
539 Last 11 Years
Buy Recommendations
92.05% 486 Buy Ratings
Companies Covered
74 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.2%1 ratings
Buy91.9%485 ratings
Hold8.0%42 ratings
Sell0.0%0 ratings

Out of 528 total stock ratings issued by Andrew Fein at HC Wainwright, the majority (91.9%) have been Buy recommendations, followed by 8.0% Hold and 0.2% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
90.5% of companies on NASDAQ
67 companies
NYSEAMERICAN
2.7% of companies on NYSEAMERICAN
2 companies
OTCMKTS
2.7% of companies on OTCMKTS
2 companies
NYSE
2.7% of companies on NYSE
2 companies
TSE
1.4% of companies on TSE
1 company

Andrew Fein, an analyst at HC Wainwright, currently covers 74 companies listed on NASDAQ, NYSEAMERICAN, OTCMKTS, NYSE and TSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
71 companies
95.9%
Industrials
2 companies
2.7%
Materials
1 company
1.4%

Andrew Fein of HC Wainwright specializes in stock coverage within the Healthcare sector, with additional focus on Industrials and Materials companies.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
57 companies
77.0%
PHARMACEUTICALS
13 companies
17.6%
TRADING COMPANIES & DISTRIBUTORS
1 company
1.4%
HEALTHCARE EQUIPMENT & SUPPLIES
1 company
1.4%
CHEMICALS
1 company
1.4%
AEROSPACE & DEFENSE
1 company
1.4%

About Andrew Fein

Mr. Fein is a Managing Director of Equity Research at H.C. Wainwright. Mr. Fein conducted more than twelve years of biotechnology equity research. Prior to joining H.C. Wainwright, Mr. Fein worked as the Head of the Healthcare Research effort at Chardan Capital Markets. Mr. Fein began his career at J.P. Morgan H&Q and first gained recognition as a Senior Analyst at Leerink Swann. After that, Mr. Fein worked as a Managing Director/Senior Biotechnology Analyst at Jefferies, Piper Jaffray and Collins Stewart. Mr. Fein has received numerous honorable mentions from the Institutional Investor All-America Research poll. Mr. Fein’s educational background includes a Bachelor of Arts degree from Yale University.
Follow on LinkedIn

Andrew Fein's Ratings History at HC Wainwright

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
8/18/2026Boost Price Target$33.16$55.00Buy
Insmed, Inc. stock logo
INSM
Insmed
8/10/2026Reiterated Rating$131.10Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
8/3/2026Reiterated Rating$5.51Buy
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
7/31/2026Reiterated Rating$493.11Buy
Biogen Inc. stock logo
BIIB
Biogen
7/30/2026Boost Price Target$205.31$251.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
7/24/2026Set Price Target$88.44$36.00
Liquidia Corporation stock logo
LQDA
Liquidia
7/23/2026Boost Price Target$89.25$130.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
7/22/2026Reiterated Rating$143.94$270.00Buy
Insmed, Inc. stock logo
INSM
Insmed
7/20/2026Reiterated Rating$108.32$220.00Buy
MetaVia Inc. stock logo
MTVA
MetaVia
7/10/2026Reiterated Rating$1.73Buy
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
6/30/2026Reiterated Rating$9.86$32.00Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
6/11/2026Reiterated Rating$5.66Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
6/8/2026Reiterated Rating$13.32$34.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
6/5/2026Boost Price Target$62.32$75.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
6/5/2026Set Price Target$63.95$28.00
Fulcrum Therapeutics, Inc. stock logo
FULC
Fulcrum Therapeutics
6/2/2026Downgrade$6.42$3.00Neutral
Catalyst Pharmaceuticals, Inc. stock logo
CPRX
Catalyst Pharmaceuticals
5/28/2026Downgrade$31.32$31.50Neutral
Protara Therapeutics, Inc. stock logo
TARA
Protara Therapeutics
5/20/2026Reiterated Rating$4.34Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
5/19/2026Lower Price Target$6.40$13.00Buy
MetaVia Inc. stock logo
MTVA
MetaVia
5/18/2026Reiterated Rating$1.11$20.00Buy
Biogen Inc. stock logo
BIIB
Biogen
5/14/2026Reiterated Rating$195.04Buy
Liquidia Corporation stock logo
LQDA
Liquidia
5/12/2026Boost Price Target$53.30$67.00Buy
Insmed, Inc. stock logo
INSM
Insmed
5/8/2026Reiterated Rating$101.30Buy
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
5/6/2026Reiterated Rating$502.47$620.00Buy
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
5/1/2026Downgrade$26.66$27.00Neutral
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
4/29/2026Boost Price Target$6.96$24.00Buy
Protara Therapeutics, Inc. stock logo
TARA
Protara Therapeutics
4/29/2026Boost Price Target$5.06$27.00Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
4/14/2026Lower Price Target$7.26$18.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
4/7/2026Boost Price Target$132.48$215.00Buy
Biogen Inc. stock logo
BIIB
Biogen
4/2/2026Boost Price Target$183.78$237.00Buy
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
3/31/2026Boost Price Target$583.78$660.00Buy
MetaVia Inc. stock logo
MTVA
MetaVia
3/27/2026Lower Price Target$1.27$20.00Buy
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
3/26/2026Boost Price Target$22.47$42.00Buy
Insmed, Inc. stock logo
INSM
Insmed
3/26/2026Boost Price Target$149.18$245.00Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
3/25/2026Reiterated Rating$13.66$34.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
3/24/2026Boost Price Target$115.73$270.00Buy
Savara Inc. stock logo
SVRA
Savara
3/16/2026Reiterated Rating$5.22Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
3/10/2026Boost Price Target$460.87$641.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
3/6/2026Boost Price Target$34.52$55.00Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
3/4/2026Boost Price Target$14.67$34.00Buy
Your $29.97 book is free today (Ad)

Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel

Normally $29.97. Today it's free. Grab your copy now.
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
3/2/2026Reiterated Rating$13.93$30.00Buy
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
2/26/2026Boost Price Target$503.28$600.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
2/24/2026Boost Price Target$117.90$255.00Buy
Insmed, Inc. stock logo
INSM
Insmed
2/23/2026Reiterated Rating$164.91$230.00Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2/17/2026Set Price Target$491.47$591.00
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2/13/2026Boost Price Target$465.02$518.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/12/2026Lower Price Target$137.44$192.00Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
2/10/2026Boost Price Target$14.22$28.00Buy
Biogen Inc. stock logo
BIIB
Biogen
2/9/2026Boost Price Target$201.18$228.00Buy
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
1/9/2026Boost Price Target$15.82$37.00Buy
MetaVia Inc. stock logo
MTVA
MetaVia
1/6/2026Boost Price Target$8.21$40.00Buy
Savara Inc. stock logo
SVRA
Savara
12/23/2025Boost Price Target$6.47$10.00Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
12/19/2025Boost Price Target$15.84$30.00Buy
Insmed, Inc. stock logo
INSM
Insmed
12/18/2025Lower Price Target$165.88$230.00Buy
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
12/18/2025Set Price Target$20.80$40.00
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
12/17/2025Boost Price Target$148.74$198.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
12/15/2025Set Price Target$91.07$200.00Buy
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
12/15/2025Reiterated Rating$18.37$35.00Buy
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
12/15/2025Boost Price Target$7.58$32.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
12/11/2025Boost Price Target$97.90$190.00Buy
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
12/9/2025Boost Price Target$94.30$134.00Buy
Kamada Ltd. stock logo
KMDA
Kamada
12/9/2025Boost Price Target$6.73$13.00Buy
Fulcrum Therapeutics, Inc. stock logo
FULC
Fulcrum Therapeutics
12/8/2025Boost Price Target$8.90$25.00Buy
Fulcrum Therapeutics, Inc. stock logo
FULC
Fulcrum Therapeutics
11/24/2025Boost Price Target$11.29$18.00Buy
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
11/21/2025Boost Price Target$556.75$620.00Buy
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
11/11/2025Lower Price Target$8.69$9.00Neutral
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
11/11/2025Boost Price Target$524.24$568.00Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
11/7/2025Boost Price Target$12.36$20.00Buy
Prothena Corporation plc stock logo
PRTA
Prothena
11/7/2025Boost Price Target$10.19$30.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
11/6/2025Boost Price Target$75.75$190.00Buy
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
11/5/2025Boost Price Target$59.91$84.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
11/4/2025Boost Price Target$27.25$50.00Buy
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
10/30/2025Boost Price Target$450.79$525.00Buy
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
10/29/2025Reiterated Rating$14.55$20.00Buy
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
10/24/2025Reiterated Rating$12.00$12.00Neutral
Alector, Inc. stock logo
ALEC
Alector
10/22/2025Lower Price Target$1.52$5.00Buy
Fulcrum Therapeutics, Inc. stock logo
FULC
Fulcrum Therapeutics
10/20/2025Reiterated Rating$8.99$12.00Buy
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
10/10/2025Reiterated Rating$54.08$54.00Neutral
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
10/10/2025Downgrade$53.88$54.00Neutral
Prothena Corporation plc stock logo
PRTA
Prothena
10/7/2025Boost Price Target$9.86$20.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
10/6/2025Reiterated Rating$22.43$35.00Buy
89BIO stock logo
ETNB
89BIO
9/19/2025Downgrade$14.96$14.50Neutral
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
9/18/2025Boost Price Target$48.12$70.00Buy
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
9/5/2025Boost Price Target$380.47$500.00Buy
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
9/4/2025Initiated Coverage$7.44$7.44Neutral
MetaVia Inc. stock logo
MTVA
MetaVia
9/4/2025Initiated Coverage$7.36$132.00Buy
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
9/4/2025Initiated Coverage$435.27$500.00Buy
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
9/4/2025Initiated Coverage$17.19$60.00Buy
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
9/4/2025Initiated Coverage$45.62$72.00Buy
89BIO stock logo
ETNB
89BIO
9/4/2025Initiated Coverage$9.24$32.00Buy
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)

Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel

Get the name and ticker of Louis Navellier's #1 AI stock free
Savara Inc. stock logo
SVRA
Savara
9/3/2025Boost Price Target$3.39$8.00Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
9/3/2025Reiterated Rating$7.55$22.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
8/15/2025Boost Price Target$46.10$75.00Buy
Savara Inc. stock logo
SVRA
Savara
8/15/2025Upgrade$3.01$5.00Buy
Arvinas, Inc. stock logo
ARVN
Arvinas
8/7/2025Lower Price Target$6.11$18.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
8/6/2025Lower Price Target$6.88$25.00Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
8/5/2025Lower Price Target$472.27$478.00Buy
Prothena Corporation plc stock logo
PRTA
Prothena
8/5/2025Reiterated Rating$6.94$14.00Buy
Biogen Inc. stock logo
BIIB
Biogen
8/1/2025Boost Price Target$128.00$194.00Buy
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
7/31/2025Set Price Target$281.95$400.00Buy
Fulcrum Therapeutics, Inc. stock logo
FULC
Fulcrum Therapeutics
7/29/2025Upgrade$7.65$12.00Buy
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
7/8/2025Boost Price Target$15.06$27.00Buy
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
6/30/2025Upgrade$4.90$23.00Buy
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
6/26/2025Reiterated Rating$46.47$60.00Buy
Biogen Inc. stock logo
BIIB
Biogen
6/26/2025Reiterated Rating$127.31$187.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
6/26/2025Reiterated Rating$22.50$32.00Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
6/23/2025Reiterated Rating$440.87$550.00Buy
Insmed, Inc. stock logo
INSM
Insmed
6/11/2025Boost Price Target$90.93$120.00Buy
Arvinas, Inc. stock logo
ARVN
Arvinas
6/2/2025Set Price Target$7.51$24.00
Savara Inc. stock logo
SVRA
Savara
5/29/2025Downgrade$2.14$2.00Neutral
PepGen, Inc. stock logo
PEPG
PepGen
5/29/2025Lower Price Target$1.58$8.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
5/28/2025Boost Price Target$15.60$35.00Buy
Prothena Corporation plc stock logo
PRTA
Prothena
5/27/2025Lower Price Target$6.58$14.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
5/19/2025Boost Price Target$22.26$32.00Buy
Foghorn Therapeutics Inc. stock logo
FHTX
Foghorn Therapeutics
5/14/2025Upgrade$4.21Strong-Buy
Annexon, Inc. stock logo
ANNX
Annexon
5/14/2025Lower Price Target$1.75$14.00Buy
Stoke Therapeutics, Inc. stock logo
STOK
Stoke Therapeutics
5/14/2025Lower Price Target$8.90$35.00Buy
Insmed, Inc. stock logo
INSM
Insmed
5/12/2025Reiterated Rating$65.08$90.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
5/12/2025Reiterated Rating$15.32$29.00Buy
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
5/9/2025Lower Price Target$11.32$38.00Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
5/9/2025Boost Price Target$4.65$16.00Buy
PepGen, Inc. stock logo
PEPG
PepGen
5/9/2025Lower Price Target$1.58$14.00Buy
Prothena Corporation plc stock logo
PRTA
Prothena
5/9/2025Lower Price Target$7.43$30.00Buy
Alector, Inc. stock logo
ALEC
Alector
5/9/2025Boost Price Target$1.11$10.00Buy
Keros Therapeutics, Inc. stock logo
KROS
Keros Therapeutics
5/8/2025Lower Price Target$13.68$25.00Buy
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
5/7/2025Lower Price Target$13.55$32.00Buy
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
5/6/2025Reiterated Rating$11.03$30.00Buy
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
5/5/2025Reiterated Rating$294.60$425.00Buy
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
5/5/2025Boost Price Target$8.95$16.00Buy
Biogen Inc. stock logo
BIIB
Biogen
5/2/2025Lower Price Target$121.39$187.00Buy
Arvinas, Inc. stock logo
ARVN
Arvinas
5/2/2025Lower Price Target$7.08$24.00Buy
AC Immune stock logo
ACIU
AC Immune
5/1/2025Lower Price Target$1.73$12.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
4/30/2025Reiterated Rating$23.44$38.00Buy
Sutro Biopharma, Inc. stock logo
STRO
Sutro Biopharma
4/29/2025Reiterated Rating$8.97$20.00Neutral
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
4/22/2025Lower Price Target$100.68$168.00Buy
Insmed, Inc. stock logo
INSM
Insmed
4/22/2025Reiterated Rating$69.51$90.00Buy
Arvinas, Inc. stock logo
ARVN
Arvinas
4/7/2025Reiterated Rating$6.56$81.00Buy
I-Mab Sponsored ADR stock logo
IMAB
I-Mab
4/4/2025Lower Price Target$0.73$7.00Buy
AC Immune stock logo
ACIU
AC Immune
4/3/2025Reiterated Rating$1.88$16.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
4/1/2025Reiterated Rating$27.99$38.00Buy
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
Keros Therapeutics, Inc. stock logo
KROS
Keros Therapeutics
4/1/2025Reiterated Rating$10.19$40.00Buy
Savara Inc. stock logo
SVRA
Savara
3/28/2025Reiterated Rating$2.78$6.00Buy
Acumen Pharmaceuticals, Inc. stock logo
ABOS
Acumen Pharmaceuticals
3/28/2025Lower Price Target$1.23$11.00Buy
Zentalis Pharmaceuticals, Inc. stock logo
ZNTL
Zentalis Pharmaceuticals
3/27/2025Reiterated Rating$1.76$10.00Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
3/26/2025Reiterated Rating$9.75$22.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
3/20/2025Reiterated Rating$14.92$29.00Buy
Stoke Therapeutics, Inc. stock logo
STOK
Stoke Therapeutics
3/19/2025Reiterated Rating$8.87$47.00Buy
Zentalis Pharmaceuticals, Inc. stock logo
ZNTL
Zentalis Pharmaceuticals
3/17/2025Reiterated Rating$1.77$10.00Buy
Sutro Biopharma, Inc. stock logo
STRO
Sutro Biopharma
3/17/2025Reiterated Rating$8.10$20.00Neutral
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
3/17/2025Reiterated Rating$12.23$46.00Buy
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
3/14/2025Reiterated Rating$12.25$20.00Buy
AC Immune stock logo
ACIU
AC Immune
3/14/2025Reiterated Rating$2.30$16.00Buy
ProQR Therapeutics N.V. stock logo
PRQR
ProQR Therapeutics
3/14/2025Boost Price Target$1.74$12.00Buy
Arvinas, Inc. stock logo
ARVN
Arvinas
3/11/2025Reiterated Rating$8.49$81.00Buy
Foghorn Therapeutics Inc. stock logo
FHTX
Foghorn Therapeutics
3/7/2025Reiterated Rating$4.50$13.00Buy
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
3/6/2025Initiated Coverage$3.06$8.00Buy
Protara Therapeutics, Inc. stock logo
TARA
Protara Therapeutics
3/6/2025Reiterated Rating$3.63$23.00Buy
Kamada Ltd. stock logo
KMDA
Kamada
3/6/2025Reiterated Rating$7.10$11.00Buy
TScan Therapeutics, Inc. stock logo
TCRX
TScan Therapeutics
3/6/2025Reiterated Rating$1.92$15.00Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
3/5/2025Reiterated Rating$3.01$12.00Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
3/5/2025Reiterated Rating$11.23$22.00Buy
Merus N.V. stock logo
MRUS
Merus
3/3/2025Reiterated Rating$47.09$85.00Buy
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
2/28/2025Lower Price Target$13.17$46.00Buy
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
2/28/2025Boost Price Target$29.98$60.00Buy
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
2/28/2025Boost Price Target$18.60$87.00Buy
Catalyst Pharmaceuticals, Inc. stock logo
CPRX
Catalyst Pharmaceuticals
2/28/2025Reiterated Rating$21.83$35.00Buy
Keros Therapeutics, Inc. stock logo
KROS
Keros Therapeutics
2/27/2025Lower Price Target$10.94$40.00Buy
Alector, Inc. stock logo
ALEC
Alector
2/27/2025Reiterated Rating$1.72$7.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
2/27/2025Reiterated Rating$18.96$27.00Buy
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
2/27/2025Reiterated Rating$318.89$425.00Buy
Fulcrum Therapeutics, Inc. stock logo
FULC
Fulcrum Therapeutics
2/26/2025Reiterated Rating$3.70$4.00Neutral
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
2/25/2025Reiterated Rating$8.29$30.00Buy
PepGen, Inc. stock logo
PEPG
PepGen
2/24/2025Reiterated Rating$2.81$16.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/21/2025Reiterated Rating$116.11$185.00Buy
Insmed, Inc. stock logo
INSM
Insmed
2/21/2025Reiterated Rating$83.61$90.00Buy
Prothena Corporation plc stock logo
PRTA
Prothena
2/21/2025Reiterated Rating$15.25$48.00Buy
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
2/18/2025Reiterated Rating$8.51$75.00Buy
Stoke Therapeutics, Inc. stock logo
STOK
Stoke Therapeutics
2/18/2025Boost Price Target$9.74$47.00Buy
Biogen Inc. stock logo
BIIB
Biogen
2/13/2025Lower Price Target$133.43$241.00Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2/11/2025Reiterated Rating$469.97$550.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
2/11/2025Reiterated Rating$15.72$38.00Buy
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
2/10/2025Reiterated Rating$10.15$75.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/7/2025Lower Price Target$150.51$185.00Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
1/31/2025Boost Price Target$438.40$550.00Buy
PepGen, Inc. stock logo
PEPG
PepGen
1/30/2025Lower Price Target$1.84$16.00Buy
Zentalis Pharmaceuticals, Inc. stock logo
ZNTL
Zentalis Pharmaceuticals
1/29/2025Lower Price Target$1.98$10.00Buy
Kamada Ltd. stock logo
KMDA
Kamada
1/10/2025Reiterated Rating$7.32$11.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
1/10/2025Reiterated Rating$14.25$38.00Buy
Catalyst Pharmaceuticals, Inc. stock logo
CPRX
Catalyst Pharmaceuticals
1/10/2025Boost Price Target$22.80$35.00Buy
CG Oncology, Inc. stock logo
CGON
CG Oncology
1/10/2025Reiterated Rating$30.24$75.00Buy
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
1/10/2025Reiterated Rating$15.68$55.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
1/3/2025Reiterated Rating$12.00$38.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
12/26/2024Initiated Coverage$11.80$38.00Buy
Fulcrum Therapeutics, Inc. stock logo
FULC
Fulcrum Therapeutics
11/14/2024Reiterated Rating$3.56$4.00Neutral
Syros Pharmaceuticals, Inc. stock logo
SYRS
Syros Pharmaceuticals
11/13/2024Reiterated Rating$2.73$1.00Neutral
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
10/18/2024Reiterated Rating$3.92$8.00Buy